文献速递脑血管病

美国2型糖尿病成人卒中院前延误改善与一级预防的成本效果比较

Cost-Effectiveness of Prehospital Delay Reduction Versus Primary Stroke Prevention in US Adults With Type 2 Diabetes.
PubMed 文献 · Stroke · 2026-04-10

研究基于NHANES 2015-2018数据,纳入1232名≥45岁无卒中史的2型糖尿病成人,用Michigan Model for Diabetes微模拟模型预测10年结局。比较现状、优化院前到达时间、全面实施4项一级预防策略三种情景。结果显示优化院前到达时间虽具成本效果,但全面一级预防带来的健康获益和经济节省远更大。

要点

  • 对2型糖尿病成人,广泛采用推荐的一级预防策略健康和经济获益远大于仅减少院前延误。

核心结论

  • 减少急性缺血性卒中院前延误可能具成本效果,但广泛采用推荐的一级预防策略对美国2型糖尿病成人带来更大的健康和经济获益。

研究设计与样本

  • 利用NHANES 2015-2018数据识别1232名≥45岁无卒中史的美国2型糖尿病成人,用Michigan Model for Diabetes微模拟模型预测10年卒中发病率、质量调整生命年和医疗费用。
  • 比较三种情景:现状(50%的AIS患者在24小时内到达,28%在3.5小时内到达,预防策略平均人群依从性)、优化院前到达时间(所有24小时内到达的卒中患者[50%]均在3.5小时内到达)、全面实施4项一级预防策略(血压控制、他汀治疗、戒烟和阿司匹林)。
  • 分析从卫生系统/支付方角度进行。

主要发现

  • 研究人群加权平均年龄64岁,男性占56.1%。

临床怎么用

  • 对2型糖尿病成人,应广泛实施血压控制、他汀治疗、戒烟和阿司匹林等推荐的一级预防策略,其健康和经济获益远大于仅减少院前延误。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Much attention has focused on reducing prehospital delay among patients with acute ischemic stroke (AIS) to facilitate delivery of highly effective but time-sensitive treatments. The relative benefits and cost-effectiveness of minimizing treatment delays versus more fully implementing primary prevention measures for AIS are unclear in high-risk populations, including US adults with type 2 diabetes. METHODS: We used data from the National Health and Nutrition Examination Survey (2015-2018) to identify US adults ≥45 years of age with type 2 diabetes and no prior stroke (N=1232). Stroke incidence, quality-adjusted life-years, and healthcare costs over 10 years were projected using the Michigan Model for Diabetes, a validated microsimulation model. Three scenarios were compared: (1) status quo (50% of patients with AIS arrive within 24 hours; 28% within 3.5 hours; average population-level adherence to preventive strategies); (2) optimized hospital arrival time (all patients with stroke arriving within 24 hours [50%] arrive within 3.5 hours); and (3) full implementation of 4 primary prevention strategies (blood pressure control, statin therapy, smoking cessation, and aspirin). Analyses were conducted from a health system/payer perspective. RESULTS: The study population has a weighted mean age of 64 and 56.1% males. Improving hospital arrival times to 50% within 3.5 hours was cost-effective (incremental cost-effectiveness ratio: $41 624 per quality-adjusted life-year gained), preventing 10 900 cases of stroke-related major disability and 6700 stroke deaths, and yielding an increase of 18 300 quality-adjusted life-years nationwide at a cost of $0.63 billion over 10 years. Universal adoption of primary prevention strategies averted 68 900 cases of stroke-related major disability and 61 900 stroke deaths with a gain of 1 418 000 quality-adjusted life-years nationwide and savings of $13.4 billion over 10 years. CONCLUSIONS: Although reducing prehospital delay in AIS treatment may be cost-effective, broad adoption of recommended primary prevention strategies for AIS in US adults with type 2 diabetes confers substantially greater health and economic benefits. The significance of preventive medicine, such as controlling hypertension and dyslipidemia, smoking cessation, and aspirin therapy, cannot be overstated for individuals with type 2 diabetes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ye W, Becker CJ, Li J, et al. Cost-Effectiveness of Prehospital Delay Reduction Versus Primary Stroke Prevention in US Adults With Type 2 Diabetes. Stroke. 2026. PMID: 41958382. doi:10.1161/STROKEAHA.126.055187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。